|Print This Page Email to a Friend|
Rodney P. Rocconi, M.D., professor and chief of Gynecologic Oncology at USA Mitchell Cancer Institute, is one of 16 oncologists to be chosen for a leadership program of the American Society of Clinical Oncology, the world’s leading professional organization for physicians and oncology professionals caring for people with cancer.
Created in 2009, the ASCO Leadership Development Program is a yearlong program designed to train future leaders in medicine by providing leadership skills training, networking opportunities and mentorship from ASCO leaders. Selection is based upon leadership experience and a commitment to making a difference in the oncology community.
"There's no greater honor than to be recognized by your peers,” Rocconi said. “I'm flattered to be joining the ASCO Leadership Development Program and looking forward to working with others to hone my leadership skills and give back to this wonderful organization."
Rocconi, who also serves as associate director of Clinical Research at MCI, is the sole gynecologic oncologist to participate in the 2016-17 class.
At MCI, Rocconi’s research interests include understanding the molecular mechanisms of chemo-resistance in ovarian cancer stem cells, as well as the genetic contributions of racial healthcare disparities in gynecologic malignancies. He is credited with more than 100 presentations at national meetings and more than 80 published articles.
"This is an honor and demonstrates our ability to compete nationally in such a prestigious program," said MCI Director Dr. Michael A. Finan. "Dr. Rocconi's experience in this program will translate into stronger leadership opportunities at not only the local level, but also on the national stage."
Rocconi’s research is supported by multiple NIH/NCI and foundation grants. He has been recognized for his work as a recipient of the Gynecologic Cancer Foundation Ovarian Cancer Research Award, the Gynecologic Oncology Group Young Investigator Research Award, and invited Associate Member of the NCI Early Detection Research Network. These experiences have allowed him to serve in national leadership roles in the Society of Gynecologic Oncology as well as chair certain U.S. Department of Defense Ovarian Cancer Research Program sections.
© 2017 USA Health System